Unknown

Dataset Information

0

Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation


ABSTRACT: Interleukin (IL)-33 cytokine plays a critical role in allergic diseases and cancer. IL-33 also has a nuclear localization signal. However, the nuclear function of IL-33 and its impact on cancer is unknown. Here, we demonstrate that nuclear IL-33-mediated activation of SMAD signaling pathway in epithelial cells is essential for cancer development in chronic inflammation. Using RNA- and ChIP-sequencing, we found that nuclear IL-33 repressed the expression of an inhibitory SMAD, Smad6, by interacting with its transcription factor, RUNX2. IL-33 was highly expressed in the skin and pancreatic epithelial cells in chronic inflammation, leading to a markedly repressed Smad6 expression as well as dramatically upregulated p-SMAD2/3 and p-SMAD1/5 in the epithelial cells. Blocking TGF-?/SMAD signaling attenuated the IL-33-induced cell proliferation in vitro and inhibited IL-33-dependent epidermal hyperplasia and skin cancer development in vivo. IL-33 and SMAD signaling were upregulated in human skin cancer, pancreatitis, and pancreatitis-associated pancreatic cancer. Collectively, our findings reveal that nuclear IL-33/SMAD signaling is a cell-autonomous tumor-promoting axis in chronic inflammation, which can be targeted by small-molecule inhibitors for cancer treatment and prevention.

SUBMITTER: Dr. Jong Ho Park 

PROVIDER: S-SCDT-EMBOJ-2020-106151 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8013835 | biostudies-literature
2021-01-28 | GSE149579 | GEO
| PRJNA629299 | ENA
| S-EPMC6377481 | biostudies-literature
| S-EPMC7478740 | biostudies-literature
| S-EPMC4104908 | biostudies-other
| S-EPMC8207976 | biostudies-literature
| S-EPMC5913134 | biostudies-literature
| S-EPMC7072890 | biostudies-literature
| S-EPMC6937274 | biostudies-literature